Analyst Ratings for Kite Pharma (KITE)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/29/2017 | Wedbush | N/A | Upgrade | Neutral (Underperform) |
N/A (N/A) |
139.10 (179.79) |
29.25% | Details |
| 8/29/2017 | BTIG | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
139.10 (179.79) |
29.25% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


